Carregant...
EUROPA: Has Anything New Been Learned With Angiotensin‐Converting Enzyme Inhibitors?
The European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA) involved 12,218 patients with stable coronary artery disease. Patients in this trial were randomized to the angiotensin‐converting enzyme inhibitor perindopril (8 mg/d) or placebo in additio...
Guardat en:
| Publicat a: | J Clin Hypertens (Greenwich) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Le Jacq Communications, Inc.
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109638/ https://ncbi.nlm.nih.gov/pubmed/14872148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2004.02846.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|